Home » Leigh Anderson

Leigh Anderson

May 08, 2008
Premium
Leigh Anderson has been appointed to the scientific advisory board of biOasis Technologies, the company said this week.
 
Anderson is the founder and CEO of the Plasma Proteome Institute, and was chief scientific officer at Large Scale Biology, where he founded the proteomics division in 1985. LSB merged with Biosource Technologies in 1999.
 
biOasis, based in British Columbia, develops and commercializes diagnostics and therapeutics for neurological diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Here We Are Again

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

What's Popular?

In Proteomics & Protein Research

  1. Pan-Cancer Mutation Study Identifies Protein Kinases Key to Tumor Suppression

    Premium

  2. Freenome, Biognosys Partner on Early Cancer Detection

  3. Copenhagen Team IDs Protein Complex Key to DNA Damage Repair

    Premium

  4. Top Down Proteomics Identifies Protein-Level Effects of KRAS Mutations in Colorectal Cancer

    Premium

  5. Waters Q1 Revenues Up 7 Percent

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.